Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-25-004055
Filing Date
2025-02-14
Accepted
2025-02-14 17:20:26
Documents
14
Period of Report
2025-01-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A wint20250214_8ka.htm   iXBRL 8-K/A 28379
  Complete submission text file 0001437749-25-004055.txt   168621

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA wint-20250124.xsd EX-101.SCH 3410
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20250124_def.xml EX-101.DEF 12176
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20250124_lab.xml EX-101.LAB 16370
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20250124_pre.xml EX-101.PRE 12446
16 EXTRACTED XBRL INSTANCE DOCUMENT wint20250214_8ka_htm.xml XML 3090
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39290 | Film No.: 25631014
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)